Mopidamol

CAS No. 13665-88-8

Mopidamol( —— )

Catalog No. M34106 CAS No. 13665-88-8

Mopidamol (RA 233) is a phosphodiesterase inhibitor, a dipyridamole derivative, with anticancer activity that prevents retinal vascular defects in experimental diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 845 In Stock
10MG 1169 In Stock
25MG 1739 In Stock
50MG 2027 In Stock
100MG 2604 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Mopidamol
  • Note
    Research use only, not for human use.
  • Brief Description
    Mopidamol (RA 233) is a phosphodiesterase inhibitor, a dipyridamole derivative, with anticancer activity that prevents retinal vascular defects in experimental diabetes.
  • Description
    Mopidamol (RA 233) is a phosphodiesterase inhibitor, a dipyridamole derivative, with anticancer activity that prevents retinal vascular defects in experimental diabetes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    13665-88-8
  • Formula Weight
    421.49
  • Molecular Formula
    C19H31N7O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(CCO)(CCO)C1=NC=2C(=NC(N(CCO)CCO)=NC2C=N1)N3CCCCC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • TP-10

    TP-10 is a selective inhibitor of PDE10A against other PDEs with IC50 of 0.8 nM.

  • (R)-(-)-Rolipram

    A more active enantiomer of the PDE4 inhibitor rolipram.

  • Mirodenafil dihydroc...

    Mirodenafil dihydrochloride is a PDE-5 inhibitor developed for the treatment of erectile dysfunction.